Philips Respironics Agrees on Consent Decree with US Government 10 Apr 2024 // GLOBENEWSWIRE Philips Foundation And March of Dimes Partner to Improve Prenatal Care Access 04 Apr 2024 // GLOBENEWSWIRE Philips convenes the Annual General Meeting of Shareholders 2024 ...
Manage My Portfolio Privacy Create Portfolio Portfolio Health Check Alert Preferences Subscriptions Premium & Pro About Premium Group Subscriptions Alpha Picks About Alpha Picks FREE Newsletters Investing Groups Learn About Investing Groups Most Popular Free Trials Top Rated Dividend Investi...
Phillips CEO Roy Jakobs issued a statement saying, "Strengthening patient safety and quality remains Philips' highest priority and the increased scrutiny will help us to improve even more. With the agreement on a consent decree for Philips Respironics in place, we now have a clear path forward t...
“These changes will have no impact on Philips Respironics’ commitment to complying with the consent decree and will ensure it can provide patients with the highest quality products most efficiently and competitively,” Philips said in a statement to thePittsburgh Post-Gazette. Philips also said it...
Philips recalled three BiPAP models because an alarm can incorrectly engage and shut down the ventilator under certain circumstances. Published May 29, 2024 Elise ReuterReporter post share post print email license Patrik Stollarz / Staff via Getty Images ...
Philips is restricted from selling many sleep and respiratory products in the U.S., per the terms of aconsent decreeit struck with the Department of Justice and FDA earlier this year. The companypreviously recalled the BiPAP machinesin 2022 because they contained contaminated plastic and in 2021...
2022 has been a very difficult year for Philips and our stakeholders, and we are taking firm actions to improve our execution and step up performance with urgency.
Philips still has to reach a settlement with the U.S. Food and Drug Administration (FDA) and is also facing lawsuits from individual patients over health problems they claim were caused by the devices. "The more significant medical litigation risk and the consent decree impact r...